Form 144 PHARVARIS N.V. For: 26 September
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pharvaris NV (PHVS)
Track today's live Pharvaris NV (PHVS) share price, performance and key data on this page with our current NASDAQ:PHVS stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Pharvaris NV share price on the NASDAQ exchange. Use the dropdown to switch exchange for the PHVS share price, head to our technical summary section, which provides analysis on Pharvaris NV share price buy/sell indicators using real-time data (or discuss the Pharvaris NV (PHVS) stock price today with other investors in the Pharvaris NV NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:PHVS share price (ISIN: NL00150005Y4) to enhance your trading decisions with our free investment tools and resources.
What Is the Pharvaris NV Share Price Today?
The Pharvaris NV share price today is 31.72.
What Is the Stock Symbol for Pharvaris NV
The stock symbol (or 'ticker') for Pharvaris NV is "PHVS."
What Stock Exchange Does Pharvaris NV Trade On?
Pharvaris NV is listed and trades on the NASDAQ stock exchange.
Is Pharvaris NV a Good Stock to Buy?
Determining whether Pharvaris NV (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:PHVS share price (ISIN: NL00150005Y4) to enhance your trading decisions with our free investment tools and resources.
What Is the Pharvaris NV Share Price Today?
The Pharvaris NV share price today is 31.72.
What Is the Stock Symbol for Pharvaris NV
The stock symbol (or 'ticker') for Pharvaris NV is "PHVS."
What Stock Exchange Does Pharvaris NV Trade On?
Pharvaris NV is listed and trades on the NASDAQ stock exchange.
Is Pharvaris NV a Good Stock to Buy?
Determining whether Pharvaris NV (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
31.14
32.05
52 wk Range
20.65
43.25
PHVS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
31.1432.05
52 wk Range
20.6543.25
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PHVS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
57.68
Upside
+81.84%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
8 analysts have revised their earnings downwards for the upcoming period
Form 4 Pharvaris N.V. For: 26 September- Investing.com
Form 4 Pharvaris N.V. For: 23 September- Investing.com
- Form 144 PHARVARIS N.V. For: 26 September
- Investing.com
- Form 4 Pharvaris N.V. For: 26 September
- Investing.com
- Form 4 Pharvaris N.V. For: 23 September
- Investing.com
- Form 4 Pharvaris N.V. For: 22 September
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Analyst Ratings
13 Buy
1 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 57.68
(+81.84% Upside)
Earnings
Latest Release
12/08/2026
EPS / Forecast
-0.70 / -0.65
Revenue / Forecast
-- / --
Compare PHVS to Peers and Sector
Metrics to compare | PHVS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPHVSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −11.5x | −11.2x | −0.4x | |
PEG Ratio | −0.75 | 0.88 | 0.00 | |
Price/Book | 6.5x | 9.0x | 2.6x | |
Price / LTM Sales | - | 12.6x | 3.1x | |
Upside (Analyst Target) | 81.8% | 54.4% | 54.8% | |
Fair Value Upside | Unlock | 0.6% | 7.6% | Unlock |
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Pharvaris NV (NASDAQ: PHVS) Share Price Today?
The Pharvaris NV stock price today is 31.72 USD.
What Stock Exchange Does Pharvaris NV (PHVS) Trade On?
Pharvaris NV is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Pharvaris NV?
The stock symbol (also called a 'ticker') for Pharvaris NV is "PHVS."
What Is the Current Pharvaris NV Market Capitalisation?
As of today, Pharvaris NV (NASDAQ: PHVS) market cap is 2.23B USD.
What Is Pharvaris NV's (PHVS) Earnings Per Share (TTM)?
The Pharvaris NV EPS is currently -2.62 (Trailing Twelve Months).
When Is the Next Pharvaris NV Earnings Date?
Pharvaris NV's next earnings report will be released on 18/11/2026.
Is PHVS a Buy or Sell From a Technical Analyst Perspective?
Based on today's Pharvaris NV moving averages and other technical indicators, the daily buy/sell signal for PHVS stock is Strong Sell.
How Many Times Has Pharvaris NV Stock Split?
Pharvaris NV has split 0 times. (See the PHVS stock split history page for full effective split date and price information.)
How Many Employees Does Pharvaris NV Have?
Pharvaris NV has 148 employees, based on their latest Companies House report.
What is the current trading status of Pharvaris NV (NASDAQ: PHVS)?
As of 01/10/2026, Pharvaris NV (PHVS) is trading at a share price of 31.72 USD, with a previous close of 31.73 USD. The stock has fluctuated within a day range of 31.14 USD to 32.05 USD, while its 52-week range spans from 20.65 USD to 43.25 USD.
What Is Pharvaris NV (PHVS) Price Target According to Analysts?
The average 12-month price target for Pharvaris NV is 57.68 USD, with a high estimate of 77.0637622 USD and a low estimate of 41.54753801 USD. 13 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +81.84% Upside potential.
What Is the PHVS Premarket Price?
PHVS's last pre-market stock price is 31.70 USD. The pre-market share volume is 740.00, and the stock has decreased by -0.03, or -0.09%.
What Is the PHVS After Hours Price?
PHVS's last after hours stock price is 31.65 USD, the stock has decreased by -0.07, or -0.22%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.